New drug takes on stubborn stomach worms
NCT ID NCT07258173
Summary
This study aims to see if a new drug called emodepside works better and is as safe as the current standard drug, albendazole, for treating a specific intestinal worm infection. It will involve about 100 teenagers and adults who are infected. Researchers will compare how well each drug clears the infection by checking stool samples before and after a single dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICHURIS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.